Skip to main content
. 2010 Jan 14;115(12):2462–2472. doi: 10.1182/blood-2009-08-239822

Figure 3.

Figure 3

GFI136S and GFI136N proteins show different subnuclear localization. (A) NIH-3T3 cells were transfected with GFI136S expression plasmid. GFI1 appears green; DNA, blue. The right column represents the merging of both staining. The numbers of cells analyzed for GFI136S are indicated. GFI136S is mainly localized in a dotted pattern. (B) NIH-3T3 cells were transfected with a GFI136N expression plasmid. The numbers of cells analyzed for GFI136N are indicated. GFI136N is localized at the nuclear border. (C) NIH-3T3 cells were transfected with either a GFI136S or GFI136N expression plasmid. Cell lysates were fractionated. Both protein variants are localized in the nuclear cell fraction and cannot be found in the cytosolic fraction. (D) Analysis of a bone marrow sample from the only available homozygous for GFI136N. As in transfected cells, GFI136N was mainly located at the nuclear/cytoplasmic border. As a control, cells from the Kasumi 1 t(8;21)-positive AML cell line were used. This cell line was originally derived from a patient with French-American-British M2 AML and is homozygous for GFI136S. (E) Nuclear matrix preparation of NIH-3T3 cells transiently transfected with expression vectors for GFI136S or GFI136N. Both variants are still attached to nuclear matrix components, although the GFI136N variant appears to be more concentrated at the nuclear membrane, consistent with our observation in regular cell transfection assays.